Avita Medical, Inc. · NASDAQ:RCEL

Avita Medical — Shareholder Meeting (December 2021)

33 slides from Avita Medical's shareholder meeting presentation, Dec 14, 2021

  1. Slide 1: Annual Meeting of Stockholders

    For personal use only Annual Meeting of Stockholders DECEMBER 14, 2021 (PST) / DECEMBER 15, 2021 (AEDT) NASDAQ: RCEL ASX: AVH ©Copyright 2021 AVITA Medical. All Rights Reserved.

  2. Slide 2: Call To Order

    Call To Order For personal use only Mr. Lou Panaccio, Chairman of the Board of Avita Medical, Inc. 2

  3. Slide 3: Welcome

    Welcome For personal use only Brief Company Overview 3

  4. Slide 4: Experiencing Technical Difficulties?

    Experiencing Technical Difficulties? For personal use only In the U.S. please call toll free: Outside the U.S. please call: +1 (888) 724-2416 +1 (781) 575-2748 4

  5. Slide 5: Introduction of Directors, Officers and Advisers

    For personal use only Introduction of Directors, Officers and Advisers

  6. Slide 6: Representatives Present Today

    Representatives Present Today For personal use only Board of Directors Officers Advisers Louis (Lou) Panaccio Michael Holder Chris Cunningham Chair of the Board of Directors Chief Financial Officer U.S. Legal Adviser – Partner, K&L Gates LLP Chair of Today’s Meeting Donna Shiroma Simon Davidson Dr M

  7. Slide 7: Introduction of Independent Registered Public Accounting Firm

    For personal use only Introduction of Independent Registered Public Accounting Firm Grant Thornton, LLP Represented by Mark Bottom

  8. Slide 8: Appointment of Inspector of Election

    For personal use only Appointment of Inspector of Election Chairman to appoint

  9. Slide 9: Report By Secretary Of Mailing

    For personal use only Report By Secretary Of Mailing Notice of Meeting

  10. Slide 10: Presentation Of List Of Stockholders

    For personal use only Presentation Of List Of Stockholders As Of Record Date Available upon request

  11. Slide 11: Report Of Quorum

    For personal use only Report Of Quorum Attendance at this meeting for a quorum

  12. Slide 12: Opening of the Polls and Overview of Voting Proposals

    Opening of the Polls and Overview of Voting Proposals For personal use only • Polls for voting on all matters are open • Proposals – The Board of Directors recommend a vote FOR all of the nominees listed at Proposal 1, and a vote FOR Proposals 2-15 12

  13. Slide 13: Election of Directors and Approval of Additional Matters

    For personal use only Election of Directors and Approval of Additional Matters

  14. Slide 14: 1: Election of Directors

    Proposal 1: Election of Directors For personal use only To elect five directors to serve a one-year term or until their respective successors have been duly elected and qualified. 1. Louis Panaccio, Chairman of the Board of Directors 2. Dr. Michael Perry, Director and Chief Executive Officer 3. Jere

  15. Slide 15: 2: Ratify Appointment of Auditor

    Proposal 2: For personal use only To ratify the appointment of Grant Thornton, LLP as the Company’s independent public accountants for the fiscal year ending June 30, 2022. 15

  16. Slide 16: 3: Bylaws Amendment for CDI Sales Facility

    Proposal 3: For personal use only To approve an amendment to the Company’s Amended and Restated Bylaws to provide for the ability of the Company to implement a sales facility with respect to those CDI holders that hold at the relevant time less than a marketable parcel of the Company’s CDIs for the

  17. Slide 17: 4: Ratify Issue of Shares

    Proposal 4: For personal use only To ratify the issue of 3,214,250 shares of common stock in the capital of the Company with an issue price of US$21.50 per share that were issued pursuant to an underwritten registered public offering that was completed in March 2021 on the terms and conditions set o

  18. Slide 18: 5: Increase Non-Executive Director Fee Pool

    Proposal 5: For personal use only To approve, for the purposes of ASX Listing Rule 10.17 and the Company’s Amended and Restated Bylaws and for all other purposes, that the maximum aggregate annual cash fee pool from which the non-executive directors of the Company may be paid for their services as m

  19. Slide 19: 6: Equity Grant to Mr. Louis Panaccio

    Proposal 6: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Mr. Louis P

  20. Slide 20: 7: Equity Grant to Professor Suzanne Crowe

    Proposal 7: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Professor S

  21. Slide 21: 8: Equity Grant to Mr. Jeremy Curnock Cook

    Proposal 8: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Mr. Jeremy

  22. Slide 22: 9: Equity Grant to Mr. Louis Drapeau

    Proposal 9: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Mr. Louis D

  23. Slide 23: 10: Equity Grant to Mr. James Corbett

    Proposal 10: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Mr. James

  24. Slide 24: 11: Equity Grant to Mr. James Corbett (New Director)

    Proposal 11: For personal use only To approve the grant of restricted stock units to acquire 8,675 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 4,925 shares of common stock of the Company (which may be represented by CDIs) to Mr. James

  25. Slide 25: 12: Equity Grant to Ms. Jan Stern Reed

    Proposal 12: For personal use only To approve the grant of restricted stock units to acquire 4,350 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 2,550 shares of common stock of the Company (which may be represented by CDIs) to Ms. Jan St

  26. Slide 26: 13: Equity Grant to Ms. Jan Stern Reed (New Director)

    Proposal 13: For personal use only To approve the grant of restricted stock units to acquire 8,675 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 4,925 shares of common stock of the Company (which may be represented by CDIs) to Ms. Jan St

  27. Slide 27: 14: Equity Grant to CEO Dr. Michael Perry

    Proposal 14: For personal use only To approve the grant of restricted stock units to acquire 95,280 shares of common stock of the Company (which may be represented by CDIs) and the grant of options to acquire 55,200 shares of common stock of the Company (which may be represented by CDIs) to the Comp

  28. Slide 28: 15: Say On Pay Advisory Vote

    Proposal 15: For personal use only Say On Pay: Advisory vote to approve the compensation of the Company’s named executive officers. 28

  29. Slide 29: 16: Other Business

    Proposal 16: For personal use only • To transact such other business as may properly come before the meeting or any adjournment or adjournments. • No other business has come before the meeting to be considered at this time. 29

  30. Slide 30: Closing of Polls

    For personal use only Closing of Polls The polls are about to close so if you have not yet voted, please do so. We will announce the results of the voting as soon as possible following the close of this meeting via announcements to be filed with the U.S. Securities and Exchange Commission and the Au

  31. Slide 31: Adjournment of Meeting and General Question and Answer Period

    For personal use only Adjournment of Meeting and General Question and Answer Period The formal business of the meeting is now closed. We invite you to now ask any questions you may have as it relates to the content of today’s meeting. Please follow the instructions provided on the Virtual Meeting Sc

  32. Slide 32: Conclusion of Meeting

    For personal use only Conclusion of Meeting

  33. Slide 33: Thank you!

    For personal use only Thank you!

AVITA Medical — Shareholder Meeting (December 2021) on 6ix